South Africa has the world’s highest AIDS burden.
Most of the reasons people don’t take their medication aren't related to the antiretrovirals themselves, but rather social and systemic issues.
Access to affordable medical treatment can save lives.
The global cancer burden especially in developing countries is exacerbated by the high cost of treatment.
French President Emmanuel Macron has an HIV blood test as part of World AIDS Day observances Dec. 1, 2017.
World AIDS Day is Dec. 1. With many advances in preventing and treating the disease, the disease has fallen from top of mind for many. An epidemiologist explains why that could be dangerous.
The largest number of HIV-exposed but uninfected children are in South Africa.
HIV negative children born to women with HIV have a greater risk of dying before their first birthday.
The WHO recommends HIV viral load testing to monitor people on ARVs.
Introducing viral load testing at health facilities can help South Africa reach the United Nations target to end AIDS.
A girl gets tested for HIV in Uganda where attempts to integrate HIV services with general health service have failed.
In Uganda stand-alone clinics for HIV treatment persist because of stigma and overcrowding.
A community health worker conducting a HIV test in a mobile clinic in a remote part of KwaZulu-Natal.
Greg Lomas / Médecins Sans Frontières
Women and children remain the focus of HIV while men are disadvantaged in accessing testing and treatment in Africa.
More than 15 000 researchers, activists and policymakers descend on Amsterdam this week for the 22nd International Aids Conference.
The HIV epidemic is far from over and it's not time to disengage, says International Aids Society President Linda-Gail Bekker.
Health workers promote exclusive breastfeeding to HIV positive mothers more than they do to mothers who are negative.
There needs to be a wide range of sexual health services for men who have sex with men.
In many parts of sub-Saharan Africa men who have sex with men encounter stigma and prejudice when accessing health services.
South Africa's data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.
Pillbox (illustration only).
A clinical trial currently underway in France could confirm that that HIV treatment can be safely reduced to just four days a week, while maintaining the same efficacy.
In rural areas where there are often fewer healthcare professionals available, traditional healers can have a role to play in promoting HIV treatment.
To get an effective vaccine for HIV/AIDS, scientists need to understand exactly how the virus works and immune system responds to it. African scientists have come one step closer.
Stigma stops people from getting tested for HIV, and staying on their treatment. Unless it's addressed, the AIDS epidemic will persist.
Antiretroviral drugs suppress the HIV virus and stop progression of the disease.
The introduction of Pre Exposure Prophylaxis drugs in Kenya aims at reducing new HIV infections among people facing substantial ongoing risk.
In the Democratic Republic of Congo, HIV is still highly stigmatised.
HIV remains a synonym for death in Kinshasa and many leave testing and treatment until it's too late. It's not common knowledge that an infected person can live a normal and healthy life.
Activists supporting the decriminalisation of sex work at the 21st International AIDS Conference in Durban, South Africa.
International AIDS Society/Abhi Indrarajan
South Africa has launched a plan to tackle HIV, TB and sexually transmitted infections -- but much depends on its implementation over the next five years.
People with a certain gene have an adverse reaction to the antiretroviral efavirenz.
Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.
Zimbabweans living with HIV who come to South Africa often have challenges remaining on their antiretroviral treatment regimens.
South Africa and Zimbabwe have made significant strides to roll out antiretrovirals. But the regional expansion of treatment programmes still needs work.